ctDNA guided management of POLE mutant GI malignancies promotes exceptional responses and prolonged survival to immunotherapy
{{output}}
Patients with unresectable Gastrointestinal cancers (GI) including advanced colorectal cancer (CRC) and gall bladder cancer (GBC) have limited treatment options. Treatment with chemotherapy is associated with limited success resulting from therapeutic resistan... ...